Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Department of Veterans Affairs |
---|---|
Information provided by: | Department of Veterans Affairs |
ClinicalTrials.gov Identifier: | NCT00108589 |
The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will be accomplished by development of a database of these patients, all of whom will have biopsy documented NASH. A placebo controlled trial will then examine the effect of S-adenosylmethionine over time on clinical outcome in these patients. It is expected that this agent will slow or halt the progression of this disease.
Condition | Intervention | Phase |
---|---|---|
Hepatitis |
Drug: S-adenosylmethionine |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study |
Official Title: | S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Study ID Numbers: | CLIN-014-03S |
Study First Received: | April 15, 2005 |
Last Updated: | May 15, 2007 |
ClinicalTrials.gov Identifier: | NCT00108589 |
Health Authority: | United States: Federal Government |
s-adenosylmethionine fatty liver obesity Non-alcoholic steatohepatitis |
Hepatitis Obesity Liver Diseases Digestive System Diseases Fatty Liver |